Suppr超能文献

经导管主动脉瓣植入术后院内卒中:英国观察性队列分析。

In-hospital stroke after transcatheter aortic valve implantation: A UK observational cohort analysis.

机构信息

Sussex Cardiac Center, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.

Division of Clinical and Experimental Medicine, Brighton and Sussex Medical School, Brighton, UK.

出版信息

Catheter Cardiovasc Interv. 2021 Mar;97(4):E552-E559. doi: 10.1002/ccd.29157. Epub 2020 Aug 11.

Abstract

OBJECTIVES

We sought to identify baseline demographics and procedural factors that might independently predict in-hospital stroke following transcatheter aortic valve implantation (TAVI).

BACKGROUND

Stroke is a recognized, albeit infrequent, complication of TAVI. Established predictors of procedure-related in-hospital stroke; however, remain poorly defined.

METHODS

We conducted an observational cohort analysis of the multicenter UK TAVI registry. The primary outcome measure was the incidence of in-hospital stroke.

RESULTS

A total of 8,652 TAVI procedures were performed from 2007 to 2015. There were 205 in-hospital strokes reported by participating centers equivalent to an overall stroke incidence of 2.4%. Univariate analysis showed that the implantation of balloon-expandable valves caused significantly fewer strokes (balloon-expandable 96/4,613 [2.08%] vs. self-expandable 95/3,272 [2.90%]; p = .020). After multivariable analysis, prior cerebrovascular disease (CVD) (odds ratio [OR] 1.51, 95% confidence interval [CI 1.05-2.17]; p = .03), advanced age at time of operation (OR 1.02 [0.10-1.04]; p = .05), bailout coronary stenting (OR 5.94 [2.03-17.39]; p = .008), and earlier year of procedure (OR 0.93 [0.87-1.00]; p = .04) were associated with an increased in-hospital stroke risk. There was a reduced stroke risk in those who had prior cardiac surgery (OR 0.62 [0.41-0.93]; p = .01) and a first-generation balloon-expandable valve implanted (OR 0.72 [0.53-0.97]; p = .03). In-hospital stroke significantly increased 30-day (OR 5.22 [3.49-7.81]; p < .001) and 1-year mortality (OR 3.21 [2.15-4.78]; p < .001).

CONCLUSIONS

In-hospital stroke after TAVI is associated with substantially increased early and late mortality. Factors independently associated with in-hospital stroke were previous CVD, advanced age, no prior cardiac surgery, and deployment of a predominantly first-generation self-expandable transcatheter heart valve.

摘要

目的

我们旨在确定可能独立预测经导管主动脉瓣植入术(TAVI)后院内卒中的基线人口统计学和程序因素。

背景

卒中是 TAVI 公认的、但罕见的并发症。然而,与手术相关的院内卒中的既定预测因素仍定义不明确。

方法

我们对英国多中心 TAVI 注册中心进行了一项观察性队列分析。主要观察指标为院内卒中的发生率。

结果

2007 年至 2015 年共进行了 8652 例 TAVI 手术。由参与中心报告的院内卒中共有 205 例,总体卒中发生率为 2.4%。单因素分析显示,球囊扩张瓣膜的植入导致的卒中明显较少(球囊扩张瓣膜 96/4613[2.08%] vs. 自扩张瓣膜 95/3272[2.90%];p=0.020)。多变量分析后,既往脑血管疾病(CVD)(比值比[OR]1.51,95%置信区间[CI]1.05-2.17;p=0.03)、手术时年龄较大(OR 1.02[0.10-1.04];p=0.05)、紧急冠状动脉支架置入术(OR 5.94[2.03-17.39];p=0.008)和较早的手术年份(OR 0.93[0.87-1.00];p=0.04)与院内卒中风险增加相关。既往心脏手术(OR 0.62[0.41-0.93];p=0.01)和植入第一代球囊扩张瓣膜(OR 0.72[0.53-0.97];p=0.03)的患者卒中风险降低。院内卒中显著增加了 30 天(OR 5.22[3.49-7.81];p<0.001)和 1 年死亡率(OR 3.21[2.15-4.78];p<0.001)。

结论

TAVI 术后院内卒中与早期和晚期死亡率显著增加相关。与院内卒中独立相关的因素包括既往 CVD、年龄较大、无既往心脏手术和植入主要为第一代自扩张经导管心脏瓣膜。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验